Locations:

Tag: hypoxia-inducible factor (HIF)

23-CNR-4344308-CQD-Hero-650×450 Ornstein

December 14, 2023/Cancer/Research

Belzutifan Shows Improvement in Progression-Free Survival for Patients with Refractory Clear-Cell Kidney Cancer

Belzutifan superior to everolimus in phase 3 clinical trial

Ophthalmic researchers Jonathan Sears, MD, and George Hoppe, MD, PhD

March 15, 2022/Ophthalmology/Ophthalmology Research

One Step Closer to a Drug Preventing Retinopathy of Prematurity

Artificially stabilizing hypoxia-inducible factor may stop the damaging effects of hyperoxia in preterm infants

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy